Canada markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.10-0.25 (-4.74%)
At close: 04:00PM EDT
5.00 -0.10 (-1.90%)
After hours: 05:44PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 28.68M
Enterprise Value -109.68k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.99
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.35

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 344.68%
S&P500 52-Week Change 328.04%
52 Week High 38.85
52 Week Low 32.78
50-Day Moving Average 35.80
200-Day Moving Average 34.98

Share Statistics

Avg Vol (3 month) 330.76k
Avg Vol (10 day) 311.01k
Shares Outstanding 55.43M
Implied Shares Outstanding 65.63M
Float 84.01M
% Held by Insiders 111.16%
% Held by Institutions 136.67%
Shares Short (Apr 30, 2024) 490.66k
Short Ratio (Apr 30, 2024) 412.2
Short % of Float (Apr 30, 2024) 42.25%
Short % of Shares Outstanding (Apr 30, 2024) 41.67%
Shares Short (prior month Mar 28, 2024) 4105.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Feb 13, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-26,109.62%

Management Effectiveness

Return on Assets (ttm)-36.63%
Return on Equity (ttm)-63.19%

Income Statement

Revenue (ttm)583.23k
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.46M
Net Income Avi to Common (ttm)-14.29M
Diluted EPS (ttm)-3.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.61M
Total Cash Per Share (mrq)3.98
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.14
Book Value Per Share (mrq)4.54

Cash Flow Statement

Operating Cash Flow (ttm)-12.18M
Levered Free Cash Flow (ttm)-7.67M